Long-term dupilumab reduces exacerbations and improves lung function in type 2 patients with/without allergic asthma

Autor: Sher, L. 1, ⁎, Corren, J. 2, Pavord, I. 3, Floquet, S. 4, ⁎, Pandit-Abid, N. 5, Radwan, A. 6, Jacob-Nara, J. 5, Deniz, Y. 6, Rowe, P. 5
Zdroj: In Revue Française d'Allergologie April 2023 63(3)
Databáze: ScienceDirect